COO  Cooper Companies Inc. (The)




Health Care


Ophthalmic Goods

Market Cap.


Vuru Grade


Current Price

+2.21 (+1.30%)

Growth Price

Overvalued by 56.60%

Company Metrics

  • P/E 40.7
  • P/S 4.45
  • P/B 3.01
  • EPS 4.23
  • Cash ROIC 7.18%
  • Cash Ratio 0.03
  • Dividend 0.06 / 0.04%
  • Avg. Vol. 402,298.00
  • Shares 48.47M
  • Market Cap. 8.34B

Company Description

The Cooper Companies, Inc., through its subsidiaries, develops, manufactures, and markets healthcare products serving the vision care and women's healthcare markets worldwide. It offers a range of soft contact lenses for the vision care market, such as toric lenses, which correct astigmatism; multifocal lenses for presbyopia; and spherical lenses that correct the common visual defects. The company... more

Download 10 Years of Financial Statements:
Income Statement   Balance Sheet   Cash Flow


Stifel Nicolaus Raises Cooper Companies Inc (COO) Price Target to $195.00
The Cerbat Gem - 18 hours ago
Cooper Companies logo Cooper Companies Inc (NYSE:COO) had its price objective upped by investment analysts at Stifel Nicolaus from $180.00 to $195.00 in a research report issued on Thursday.
Stifel Nicolaus Maintains a Buy Rating on The Cooper Companies (NYSE:COO) and ... - Press Telegraph
Shares Of The Cooper Companies (NYSE:COO) Rated As Buy By Analysts At Stifel ... - Fiscal Standard
The Cooper Companies Inc (COO) President & CEO Robert S Weiss Sold $24.8 ... - Jun 30, 2016
The Cooper Companies Inc is a medical device company. Through its subsidiaries, it manufactures products for contact lens wearers and supplies women's health clinicians with products and treatment options to improve the delivery of healthcare to women.
Cooper Companies Inc (COO) VP Sells $334620.00 in Stock - The Cerbat Gem
Cooper Companies Inc (COO) Director Sells $1700000.00 in Stock - Community Financial News
Cooper Companies Inc (NYSE:COO) Median Sales Estimate At $539.388
Equities Focus - 6 hours ago
According to Zacks, the consensus EPS estimate of Cooper Companies Inc (NYSE:COO) is $2.23 for the quarter ended 2016-10-31.
Baird Says Buy Cooper Companies At Current Levels
Benzinga - Jun 24, 2016
Cooper Companies Inc (NYSE: COO) hosted investor meetings this week. Following meetings with management, Baird's Jeff D. Johnson maintained an Outperform rating for the company, with a price target of $185.
THE COOPER COMPANIES INC. (NYSE:COO) Financial Condition Compared to S&P 500
CML News - Jun 6, 2016
The Cooper Companies Inc. (NYSE:COO) has a Return on Assets of 5.05%. To compare, the S&P 500 oscillates between 1% and 4%.
Cooper Companies Inc (NYSE:COO) Received An ABR Of 1.64
Markets Daily - 11 hours ago
Sell-side analysts tend to use differing terminologies, based on their research firms, to define their buy/sell recommendations. As such, it is recommended that retail investors limit themselves to a few research brokers, in order to ensure that they ...
Cooper Companies Inc. (The) (COO) is Trading Lower on Unusual Volume for June 27 - Jun 28, 2016
Cooper Companies Inc. (The) (COO) experienced unusually high volume on Jun. 27, as the stock lost 2.28% to a closing price of $162.99.
The Cooper Companies Acquires Assets of Recombine
GlobeNewswire (press release) - May 25, 2016
PLEASANTON, Calif., May 25, 2016 (GLOBE NEWSWIRE) -- The Cooper Companies, Inc. (NYSE:COO) today announced that CooperSurgical has acquired the commercial assets of Recombine Inc., a clinical genetic testing company specializing in carrier ...
Cooper Companies Inc (NYSE:COO) Yearly EPS Forecast At $2.17 - Investor Newswire
Cooper Companies Inc (NYSE:COO) Quarterly EPS From Continuing Operations ... - Enterprise Leader
Cooper Companies Inc (COO) is Reiterated by Stifel to Buy, Raises Price Target ...
Market Digest - 3 hours ago
Cooper Companies Inc (COO) was Reiterated by Stifel to “Buy” according to the research note released today. The brokerage firm has raised the Price Target to $ 195 from a previous price target of $180 .
Trade of the Day: Set Your Sights on COO Stock - Jun 17, 2016
Cooper Companies Inc (COO) - COO stock hit a new year-to-date high above $173 on June 3, following the release of the health care company's fiscal second-quarter earnings.